Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Multidirectional Radio Surgery Treats Brain Cancer

By HospiMedica International staff writers
Posted on 30 Oct 2009
A new study claims that stereotactic radiosurgery (SRS) is the preferred method of treating cancer patients with brain metastases.

Researchers at the University of Texas MD Anderson Cancer Center (Houston, TX, USA) randomly assigned 58 patients with one to three newly diagnosed brain metastases to SRS plus whole brain radiation therapy (WBRT) or SRS alone from Jan 2, 2001, to Sept 14, 2007. More...
The patients were stratified by recursive partitioning analysis class, number of brain metastases, and radioresistant histology. The randomization sequence was masked until assignation, at which point both clinicians and patients were made aware of the treatment allocation. The primary endpoint was neurocognitive function, objectively measured as a significant deterioration (5-point drop compared with baseline) in the Hopkins Verbal Learning Test-Revised (HVLT-R) total recall at 4 months.

The researchers reported that the trial was stopped by the data monitoring committee--according to early stopping rules--on the basis that there was a high probability (96%) that patients randomly assigned to receive SRS plus WBRT were significantly more likely to show a decline in learning and memory function at 4 months than patients assigned to receive SRS alone. At four months, there were four deaths (13%) in the group that received SRS alone, and eight deaths (29%) in the group that received SRS plus WBRT. On the other hand, 73% of patients in the SRS plus WBRT group were free from CNS recurrence at one year, compared with 27% of patients who received SRS alone. In the SRS plus WBRT group, one case of grade 3 toxicity was attributed to radiation treatment; in the group that received SRS, one case of grade 3 toxicity (aphasia) was attributed to radiation treatment; two cases of grade 4 toxicity in the group that received SRS alone were diagnosed as radiation necrosis. The study was published in the October 5, 2009, online edition of the Lancet Oncology.

"Despite this difference in recurrence rates, we would still advise against WBRT because the risks of learning dysfunction outweigh the benefits of freedom from progression,” said lead author Eric L. Chang, M.D., an associate professor in the department of radiation oncology. "With close monitoring, salvage resections or additional radiation can be performed as necessary and patients who receive SRS alone will fare better with their quality of life intact.”

Stereotactic surgery is a minimally invasive form of surgical intervention, which makes use of a three-dimensional (3D) coordinates system to locate small targets inside the body and to perform a surgical procedure on them. Guide bars in the x, y, and z directions (or alternatively, in polar coordinates) are fitted with high precision vernier scales that allow the neurosurgeon to position the point of a probe inside the brain through a small trephine hole in the skull at the calculated coordinates for the desired structure.

Related Links:
University of Texas MD Anderson Cancer Center



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.